OtoNexus

OverviewSuggest Edit

OtoNexus Medical Technologies, Inc. is commercializing a ground-breaking, patented, medical device to rapidly and accurately diagnose middle ear infections, called Otitis Media (OM), in children and adults. In 2013, the American Academy of Pediatrics issued strong new guidelines for the diagnosis, treatment and management of Acute Otitis Media. These guidelines focus on reducing 
the use of antibiotics and increasing scrutiny on accuracy in diagnoses, stating, among other things, that antibiotics should only be prescribed when the diagnosis is unequivocal. The problem is that, with current tools, the diagnoses are rarely unequivocal, especially in the difficult differentiation between viral and bacterial infections. Thus, the physicians were given very clear guidelines, but no good tools with which to comply.
TypePrivate
Founded2010
HQSeattle, US
Websiteotonexus.com

Latest Updates

Employees (est.) (Sept 2020)14
Cybersecurity ratingAMore

Key People/Management at OtoNexus

Caitlin Cameron

Caitlin Cameron

Chair of the Board and Chief Executive Officer
Rhonda F. Rhyne

Rhonda F. Rhyne

Director
George A. Gates

George A. Gates

Co-Founder and Chief Medical Officer, Director
John Alleman

John Alleman

Chief Technology Officer
Mark A. Moehring

Mark A. Moehring

Co-Founder and Chief Technology Officer, Director
Gina Kelly

Gina Kelly

Chief Product and Marketing Officer
Show more

OtoNexus Office Locations

OtoNexus has an office in Seattle
Seattle, US (HQ)
Seattle, WA, USA
Show all (1)

OtoNexus Financials and Metrics

Summary Metrics

Founding Date

2010

OtoNexus total Funding

$11.3 m

OtoNexus latest funding size

$7.80 m

Time since last funding

4 years ago

OtoNexus investors

OtoNexus's latest funding round in January 2017 was reported to be $7.8 m. In total, OtoNexus has raised $11.3 m
Show all financial metrics

OtoNexus Cybersecurity Score

Cybersecurity ratingPremium dataset

A

90/100

SecurityScorecard logo

OtoNexus Online and Social Media Presence

Embed Graph

OtoNexus News and Updates

Highest Honor at Investor Capital Expo Goes to OtoNexus Which May Lead to Fewer Surgeries and Serious Inner Ear Infections

The over 200 angel investors participating in the Keiretsu Forum Mid-Atlantic's Investor Capital Expo selected OctoNexus as the winner of the Stephen M. Goodman Most Valued Company Award for 2019. This honor has advantages prior winners in funding and development.

Revolutionary Medical Device Company - OtoNexus - Wins WCD Startup Pitch Competition for Women-Led Companies

SANTA CLARA, Calif., May 28, 2019 /PRNewswire/ -- A woman-led medical device company whose product immediately diagnoses viral and bacterial ear infections in children, and therefore reduces antibiotic overuse, has just won WomenCorporateDirectors Foundation's (WCD) inaugural Launch Zone...

OtoNexus Frequently Asked Questions

  • When was OtoNexus founded?

    OtoNexus was founded in 2010.

  • Who are OtoNexus key executives?

    OtoNexus's key executives are Caitlin Cameron, Rhonda F. Rhyne and George A. Gates.

  • How many employees does OtoNexus have?

    OtoNexus has 14 employees.

  • Who are OtoNexus competitors?

    Competitors of OtoNexus include Vaporox, Origin Sciences and Outset Medical.

  • Where is OtoNexus headquarters?

    OtoNexus headquarters is located at Seattle, WA, USA, Seattle.

  • Where are OtoNexus offices?

    OtoNexus has an office in Seattle.

  • How many offices does OtoNexus have?

    OtoNexus has 1 office.